Matches in Wikidata for { <http://www.wikidata.org/entity/Q91319329> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q91319329 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91319329 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91319329 description "scientific article published on 02 February 2019" @default.
- Q91319329 description "wetenschappelijk artikel" @default.
- Q91319329 description "наукова стаття, опублікована в лютому 2019" @default.
- Q91319329 name "Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program" @default.
- Q91319329 name "Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program" @default.
- Q91319329 type Item @default.
- Q91319329 label "Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program" @default.
- Q91319329 label "Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program" @default.
- Q91319329 prefLabel "Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program" @default.
- Q91319329 prefLabel "Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program" @default.
- Q91319329 P1433 Q91319329-1EE8F2E5-D5E4-490C-875C-A9D7ADB55D50 @default.
- Q91319329 P1476 Q91319329-338193D8-4171-4E94-95F3-71BF49ACFDC5 @default.
- Q91319329 P2093 Q91319329-058A6E77-A95F-41D6-8848-F33FF66DF027 @default.
- Q91319329 P2093 Q91319329-1B1AB72F-08FE-42B1-BBFC-1FDF6B3EFC29 @default.
- Q91319329 P2093 Q91319329-28C0D35B-2652-4058-B8A2-79BC5875369C @default.
- Q91319329 P2093 Q91319329-2C559678-F605-4425-8E06-230A1469DC5F @default.
- Q91319329 P2093 Q91319329-34EC55BF-F04C-4512-8ECA-7BF3864A2777 @default.
- Q91319329 P2093 Q91319329-42BD7BD0-7025-4FE7-8B07-5E6B5EE60518 @default.
- Q91319329 P2093 Q91319329-48903138-6780-4D65-99FB-FA00B524E7FC @default.
- Q91319329 P2093 Q91319329-4D84A2FC-1DE6-418C-A143-5A402F1A4905 @default.
- Q91319329 P2093 Q91319329-561DF59C-5241-43DA-A68B-82C90C2E1C73 @default.
- Q91319329 P2093 Q91319329-6D5AF16E-215E-4BCE-AEBB-FB53B712D4C9 @default.
- Q91319329 P2093 Q91319329-82585763-C5CA-4484-B188-5310C30F0A82 @default.
- Q91319329 P2093 Q91319329-A9CBFDA9-93F2-428C-9106-A03F4A18339F @default.
- Q91319329 P2093 Q91319329-DBB10588-3A6D-4D3B-9622-6DADBA5D3784 @default.
- Q91319329 P2093 Q91319329-FFB941AF-E0E2-454D-B429-B52F0F868EE9 @default.
- Q91319329 P275 Q91319329-bd3dd631-ceb9-4177-a401-ee8c5705b2a6 @default.
- Q91319329 P304 Q91319329-28E3B38E-D0E7-40DA-A62F-44F6C464CB5B @default.
- Q91319329 P31 Q91319329-6498D96C-3530-4143-8FB4-0E1724AE4B11 @default.
- Q91319329 P356 Q91319329-FC96DFCE-07DB-47E4-B727-E708AEB864E2 @default.
- Q91319329 P433 Q91319329-35D5D59F-9E99-48A3-AA80-0C26B3BD079A @default.
- Q91319329 P478 Q91319329-DFD14D57-925F-4338-809D-B2522962DDA8 @default.
- Q91319329 P50 Q91319329-85FF7433-BD0D-40CF-A8C8-6DF88093A123 @default.
- Q91319329 P577 Q91319329-F22B0C9A-330A-4C47-BE1F-9B647A2D07BE @default.
- Q91319329 P6216 Q91319329-fc06dcb2-f0d6-4b01-87cb-659a62bda14f @default.
- Q91319329 P698 Q91319329-2FC4F745-4175-4A07-948F-40E3E4DFB4CC @default.
- Q91319329 P921 Q91319329-71C3D7F9-B864-4FE3-ABB1-86331F9D6591 @default.
- Q91319329 P932 Q91319329-F960EFBB-BDB3-4323-A25E-7E31AFFF4DC1 @default.
- Q91319329 P356 S12253-019-00607-2 @default.
- Q91319329 P698 30712192 @default.
- Q91319329 P1433 Q26842743 @default.
- Q91319329 P1476 "Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program" @default.
- Q91319329 P2093 "Beáta Deák" @default.
- Q91319329 P2093 "Gábor Mikala" @default.
- Q91319329 P2093 "Hussain Alizadeh" @default.
- Q91319329 P2093 "Judit Demeter" @default.
- Q91319329 P2093 "László Váróczy" @default.
- Q91319329 P2093 "Márk Plander" @default.
- Q91319329 P2093 "Mónika Pető" @default.
- Q91319329 P2093 "Szabolcs Kosztolányi" @default.
- Q91319329 P2093 "Tamás Schneider" @default.
- Q91319329 P2093 "Tamás Szendrei" @default.
- Q91319329 P2093 "Zsolt Nagy" @default.
- Q91319329 P2093 "Árpád Bátai" @default.
- Q91319329 P2093 "Árpád Illés" @default.
- Q91319329 P2093 "Árpád Szomor" @default.
- Q91319329 P275 Q20007257 @default.
- Q91319329 P304 "1615-1620" @default.
- Q91319329 P31 Q13442814 @default.
- Q91319329 P356 "10.1007/S12253-019-00607-2" @default.
- Q91319329 P433 "4" @default.
- Q91319329 P478 "25" @default.
- Q91319329 P50 Q85347734 @default.
- Q91319329 P577 "2019-02-02T00:00:00Z" @default.
- Q91319329 P6216 Q50423863 @default.
- Q91319329 P698 "30712192" @default.
- Q91319329 P921 Q422252 @default.
- Q91319329 P932 "6815275" @default.